Deere & Co (DE) Stock News

Rosen Law Firm is encouraging investors with losses exceeding $100K in Regencell Bioscience Holdings Limited, Calix, Inc., and Wise Group plc to join securities class action lawsuits. The firm is seeking lead plaintiffs before the June 23, 2026 deadline. Regencell is accused of making false statements regarding market manipulation vulnerability and regulatory risks.

Tourmaline Oil Corp. announced a quarterly cash dividend of $0.50 per share payable on June 30, 2026, and held its annual shareholder meeting on June 3, 2026, where ten directors were elected. The company is Canada's largest natural gas producer focused on low-cost development in the Western Canadian Sedimentary Basin.

A securities fraud class action lawsuit has been filed against AeroVironment, Inc. for allegedly understating competition risks related to the SCAR program. The company faced a U.S. Space Force stop work order in January 2026, followed by contract termination in March 2026, resulting in a $151.3 million goodwill impairment. The Space Force subsequently announced plans to diversify suppliers and use commercial off-the-shelf solutions instead of single-vendor solutions. Investors who purchased securities between June 25, 2025 and March 10, 2026 can claim damages by July 27, 2026.

AeroVironment investors who purchased securities between June 25, 2025 and March 10, 2026 can seek lead plaintiff status in a class action lawsuit. The suit alleges AeroVironment made false statements about competition for the U.S. Space Force's SCAR program contract. After a stop work order and contract termination, the company reported a $151.3 million goodwill impairment and significant operating losses, causing stock declines of 6-17% on successive announcements.

VersaBank (NASDAQ: VBNK) announced a quarterly cash dividend of CAD $0.025 per common share, payable July 31, 2026, to shareholders of record as of July 10, 2026. The dividends are eligible for tax purposes.

Rosen Law Firm has filed securities class action lawsuits against POET Technologies, Immutep Ltd., and DNOW Inc., alleging material misstatements and omissions. POET Technologies is accused of misrepresenting its tax status as a PFIC and having an executive violate non-disclosure agreements. Investors with losses exceeding $100,000 are encouraged to join the class actions before the June 29, 2026 lead plaintiff deadline.

Law firm Bragar Eagel & Squire is investigating Claritev Corporation following a DOJ criminal price-fixing investigation into the company's Data iSight pricing tool, reported by The Capitol Forum on May 14, 2026. The announcement triggered a sharp 41% stock price decline, dropping from $23.47 to $13.87 per share. The firm is seeking stockholders who suffered losses to discuss potential legal claims.

The DEA's rescheduling of marijuana from Schedule I to Schedule III in April 2026 was initially seen as historic but has had muted impact. The rescheduling only applies to medical marijuana and provides limited benefits like IRS Section 280E relief. Canopy Growth, a major Canadian cannabis company, cannot fully capitalize on these changes due to its non-controlling interest in its U.S. affiliate Canopy USA, whose results remain unconsolidated. The analyst concludes the rescheduling won't materially affect Canopy Growth soon and does not recommend the stock as a buy.

Sika has appointed Philipp Irniger as Head Construction and member of the executive board effective June 1, 2026, succeeding Ivo Schädler who retires after 30+ years. The company also created a new Chief Digital & Information Officer position, with Jochen Werling taking the role to accelerate digital transformation and the Fast-Forward program.

Rosen Law Firm reminds Stellantis N.V. investors of the June 8, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Stellantis made false statements about its earnings growth potential and electrification strategy, claiming the company was not well-positioned for battery-powered electric vehicle growth and would need to take significant charges to adjust its priorities.

Rosen Law Firm announces a securities class action lawsuit against Medpace Holdings, Inc. for allegedly making false statements about backlog cancellation rates and providing misleading growth projections. Investors who purchased MEDP stock between April 22, 2025 and February 9, 2026 may be eligible for compensation. The deadline to serve as lead plaintiff is June 8, 2026.

Verra Mobility Corporation received a termination notice from Avis Budget Group effective September 2026, expected to reduce 2026 annualized revenue by $135-145 million and segment profit by $120-125 million. The announcement triggered a 71% stock price decline from $13.08 to $3.85 per share on May 27, 2026. Law firm Kirby McInerney LLP is investigating potential securities law violations related to the termination.

JIADE LIMITED (Nasdaq: JDZG) announced the completion of an additional closing of $8.64 million in Class A ordinary shares on June 1, 2026, bringing total proceeds to $12.0 million from its registered direct offering. The company issued 3.6 million shares at $2.40 per share following a 10-for-1 share consolidation. Net proceeds will be used for general corporate purposes and working capital.

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR THE DISSEMINATION, DISTRIBUTION, RELEASE OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES/ CALGARY, AB , June 1, 2026 /CNW/ - Northstar Clean Technologies Inc. (TSXV: ROOF ) (OTCQB: ROOOF ) (" Northstar " or the " Company ") is pleased to announce its financial and operating results for the three-month period ended March 31, 2026. Selected financial and operational information is set out below and should be read in conjunction with the Company's March 31, 2026 financial statements and the related management's discussion and analysis, which are available for review at www.sedarplus.ca or the Company's website at www.northstarcleantech.com . "The first quarter of 2026 was focused on strategic execution for Northstar, highlighted by the advancement of our U.S. expansion plans, including the selection of Baltimore, MD as our first U.S. location, and the strengthening of our financial position to support the ramp up of the Empower Calgary facility and future growth," said Aidan Mills, President & CEO of Northstar. "This month, ramp up activities at the Empower Calgary Facility have been ongoing and, we're successfully processing front-to-back without encountering the material transfer and water processing issues initially at 80tpd. We're getting very close to achieving 100tpd at the Calgary Facility, a key operational milestone aligned with ERA Milestone 4 and an important step toward commercial production." Q1 2026 Highlights January 2026: Northstar Selects Baltimore, Maryland as First United States Expansion Location January 2026: Northstar Raises $1.0 Million in Debenture Proceeds February 2026: Northstar Extends Maturing Convertible Debentures March 2026: Northstar Announces US$10 Million Non-Binding Term Sheet March 2026: Northstar Closes US$9 Million First Tranche of US$10 Million

John Hancock Investment Management announced quarterly distributions for four closed-end funds on June 1, 2026. The funds declared distributions ranging from $0.1535 to $0.6500 per share, with payment scheduled for June 30, 2026. Distributions may include net investment income, capital gains, and return of capital.

John Hancock Investment Management announced monthly distributions for its closed-end funds on June 1, 2026. The Tax-Advantaged Dividend Income Fund (HTD) will distribute $0.1580 per share monthly, while the Premium Dividend Fund (PDT) will distribute $0.0825 per share monthly. All distributions are scheduled for payment on June 30, 2026.

Stewart Information Services Corporation (NYSE: STC) announced a cash dividend of $0.525 per share for Q2 2026, payable on June 30, 2026, to shareholders of record as of June 15, 2026. The global real estate services company continues its dividend distribution to common stockholders.

Jade Biosciences reported positive interim Phase 1 results for JADE101, an anti-APRIL monoclonal antibody for IgA nephropathy treatment. The drug demonstrated ~70% IgA reductions sustained at 12 weeks with a favorable safety profile and potential for every-12-week dosing. Phase 2 trials are underway with Phase 3 expected to initiate in H1 2027.

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE U.S./ CALGARY, AB , June 1, 2026 /CNW/ - Source Rock Royalties Ltd. ("Source Rock") (TSXV: SRR ), a pure-play oil and gas royalty company with an established portfolio of oil royalties and Crown mineral leases, announces results for the three-month period ended March 31, 2026 ("Q1 2026"). President's Message - Corporate Update During Q1 2026, we experienced two very different market environments. Oil prices were below $60.00 USD per barrel in January and remained very weak for almost all of February; which followed extended oil price weakness throughout the second half of 2025. These prolonged lower oil prices resulted in less new drilling activity on our royalty lands and reduced new production to offset natural declines from consistent drilling activity in 2024 and the first half of 2025. In addition, our production volume royalty had a scheduled decline from 70 bbl/d to 39 bbl/d that went into effect on January 1, 2026. This weakness reversed quickly when oil prices spiked in March, which changed the dynamic across our royalty lands for the first quarter and improved our outlook for the remainder of 2026. March royalty production rebounded from earlier in Q1 2026 to average 204 boe/d and royalty revenue for the month was approximately $623,000. Seven new horizontal wells began producing in March on our central Alberta (4) and S.E. Saskatchewan (3) royalty lands. The higher oil price environment not only increases the royalty revenue from our existing production due to our ~90% oil royalty production ratio, but it also positively changes our expectations for new drilling on our royalty lands. In particular, the operator of our Clearwater royalty lands recently disclosed that they have added a second rig to the property and anticipate an increase in the number of Clearwater horizontal wells to b

Rosen Law Firm is reminding investors in Regencell Bioscience Holdings Limited, ChampionX Corporation, and Commvault Systems, Inc. of upcoming lead plaintiff deadlines in securities class action lawsuits. The lawsuits allege that defendants made false or misleading statements regarding market manipulation vulnerabilities, regulatory risks, and other material misstatements that caused investor damages.

A securities class action lawsuit has been filed against Gossamer Bio (GOSS) alleging executives concealed placebo response risks in the Phase 3 PROSERA trial for seralutinib. The trial failed to meet its primary endpoint on February 23, 2026, causing an 80% stock price decline. The complaint claims management misled investors about trial design and patient recruitment despite knowing of significant placebo effects, particularly at Latin American sites.

A securities class action lawsuit has been filed against LKQ Corporation for allegedly misrepresenting the benefits and integration prospects of its FinishMaster acquisition. LKQ claimed the acquisition presented 'minimal integration risk' and was a 'highly synergistic opportunity,' but FinishMaster subsequently lost major customers and market share. Investors who purchased LKQ stock between February 27, 2023 and July 23, 2025 may be eligible for compensation. The lead plaintiff deadline is June 22, 2026.

A securities class action lawsuit has been filed against Babcock & Wilcox Enterprises, Inc. (BW) for allegedly making false and misleading statements regarding a Power Generation Contract with Applied Digital. The lawsuit claims that B&W's largest shareholder BRC Group Holdings stood on both sides of the contract and that Applied Digital did not actually need the products/services, raising questions about revenue recognition. Investors who purchased BW securities between November 5, 2025 and March 11, 2026 may be eligible for compensation. The lead plaintiff deadline is June 15, 2026.

Rosen Law Firm has issued deadline notices for securities class action lawsuits against Gossamer Bio, Upstart Holdings, and POET Technologies. Investors with losses exceeding $100K are encouraged to secure counsel before upcoming deadlines. The lawsuits allege false and misleading statements regarding clinical trial design and other material facts.

Rosen Law Firm is notifying investors in Upstart Holdings, Inc. (NASDAQ: UPST) of a June 8, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Upstart made false and misleading statements regarding its Model 22 AI risk assessment tool, claiming it frequently overreacted to negative macroeconomic signals, overstated accuracy, and negatively impacted revenue results, rendering the company's 2025 revenue guidance unreliable.

Rosen Law Firm reminds SES AI Corporation investors who purchased securities between January 29, 2025 and March 4, 2026 of the June 26, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that SES AI made materially false statements regarding business prospects, overstated expected results from limited-operation deals, created artificial revenue through circular transactions, and failed to disclose material logistics constraints affecting Q4 2025 revenues and 2026 guidance.

Rosen Law Firm reminds investors in New Era Energy & Digital, Inc. (NUAI) who purchased securities between November 6, 2024 and December 29, 2025 of the June 1, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges the company made false statements about its Texas Critical Data Centers project and was involved in a fraudulent scheme regarding oil and gas wells in New Mexico, resulting in misleading financial results.

A class action lawsuit has been filed against FS KKR Capital Corp. alleging the company made false statements about portfolio restructuring, investment valuations, and dividend sustainability. The lawsuit follows significant declines in net asset value, increased non-accrual investments, and dividend cuts announced in earnings reports from August 2025 and February 2026. Lead plaintiff motions must be filed by July 6, 2026.

A securities class action lawsuit has been filed against Medpace Holdings, Inc. alleging that defendants made false and misleading statements regarding the company's backlog cancellation rates. The lawsuit claims defendants misrepresented cancellation rates as 'well behaved' and provided overly positive growth expectations that could not be sustained. Investors with losses exceeding $100,000 are encouraged to join the class action before the June 8, 2026 lead plaintiff deadline.

Canborsa, a decentralized exchange built on Canton Network, launched its beta platform enabling non-custodial trading of tokenized real-world assets including stocks, commodities, and cryptocurrencies with up to 20x leverage. The platform offers 24/7 trading without KYC requirements or intermediaries, supporting assets like Bitcoin, Ethereum, Apple, Nvidia, Tesla, Gold, and Oil.